Alternative Splicing: A Promising Target for Pharmaceutical Inhibition of Pathological Angiogenesis?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|35|3864-3876

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.35, 2010-01, pp. : 3864-3876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Falcipain Inhibition as a Promising Antimalarial Target

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-03 ,pp. : 408-444

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis

By  

Current Medicinal Chemistry, Vol. 24, Iss. 11, 2017-05 ,pp. : 1147-1157

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 7, 2013-09 ,pp. : 735-748

Bentham Science Publishers

Access to resources Recommend Favorite

LRP/LR as an Alternative Promising Target in Therapy of Prion Diseases, Alzheimer's Disease and Cancer

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 1, 2009-02 ,pp. : 69-80

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesteryl Ester Transfer Protein: Pharmacological Inhibition for the Modulation of Plasma Cholesterol Levels and Promising Target for the Prevention of Atherosclerosis.

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-04 ,pp. : 257-264

Bentham Science Publishers

Access to resources Recommend Favorite